DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
67	多発性嚢胞腎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00541853 (ClinicalTrials.gov)	December 2007	9/10/2007	CCB Safety Study in Treatment of Hypertension of ADPKD	Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD Patients	Kidney, Polycystic, Autosomal Dominant	Drug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agents	Kyorin University	Ministry of Health, Labour and Welfare, Japan	Not yet recruiting	20 Years	60 Years	Both	150	Phase 4	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

December 2007

9/10/2007

CCB Safety Study in Treatment of Hypertension of ADPKD

Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD Patients

Kidney, Polycystic, Autosomal Dominant

Drug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agents

Kyorin University

Ministry of Health, Labour and Welfare, Japan

Not yet recruiting

20 Years

60 Years

Both

150

Phase 4

Japan